@BioChemAdda | BioTech Adda - No. 1 #Jobs, #Events, & #News Portal. #Biotech Jobs, Biotech #Vacancy, Biotech #Naukri, #Chemistry Jobs, #Biosciences #Careers.
San Diego, CA
Joined November 2009
- Tweets5K
- Following881
- Followers1.8K
- Likes1.1K
Future proof your biotech career with the required skills - Admissions Open - Biocon KGI Certificate Program in Biosciences - mailchi.mp/890157e5706b/admi…
Learn the applied knowledge on various Good Regulatory Practices (GRA) - Admissions Open for Certificate Program in GRA - mailchi.mp/a28d0700fa8e/admi…
Biocon Ramaiah Certificate Program in QC Analytical, Batch 3 - mailchi.mp/c2aaa68146a9/appl…
Please mention @BioChemAdda while applying to this program.
admission.bioconacademy.com/…)
$ARVN - Arvinas to Present at the Guggenheim Healthcare Talks: 2021 Oncology Day
ir.arvinas.com/news-releases…
$AUTL - Autolus Announces Proposed Public Offering in the United States
autolus.gcs-web.com/news-rel…
$CSII - First Patient in Europe Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System
investors.csi360.com/news-re…
$CORT - Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate Update
ir.corcept.com/news-releases…
$NAVB - Navidea Biopharmaceuticals Announces Submission of Formal Type B Meeting Request with FDA and Launch of NAV3-32 Phase 2B Trial in Rheumatoid Arthritis
navidea.com/news-media/press…
$AVIR - Atea Pharmaceuticals Announces Publication of Preclinical Data Highlighting Potent Activity of AT-527 Against SARS-CoV-2
ir.ateapharma.com/news-relea…
$RVMD - Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
benzinga.com/pressreleases/2…
$IRWD - Ironwood Pharmaceuticals Announces CEO Transition
benzinga.com/pressreleases/2…
$BXRX - Baudax Bio Announces $17.6 Million Offering Priced At-the-Market under Nasdaq Rules
benzinga.com/pressreleases/2…
$SRNE - Sorrento Announces Subsidiary Company - ADNAB, Inc. - to Develop and Commercialize ADNAB™ Platform Products for Hematological Malignancies and Solid Tumors Based on an Exclusive Technology License From the Mayo Clinic - manufacture of antibody-drug conjugates (ADC)
$FOLD - Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene Therapy at the 17th Annual WORLDSymposium™ 2021
$FOLD - Amicus announces early-stage interim data for AT-GTX-502 in Batten disease seekingalpha.com/news/365964…
Hey @WSBChairman...
please suggest...
$srne is it worth (to the moon).
Currently in $12-13 range. But few analysts project it to be worth of $35.
BioChem Adda retweeted
A recent study coming from #France found no evidence of a strong antiviral activity or clinical benefit of the combination of #hydroxychloroquine and #azithromycin for the treatment of hospitalized patients with severe #COVID19
#coronavirus #COVID
sciencedirect.com/science/ar…
